Physician profile
John C Shallcross
NPI 1417937731
$2,569.05
in general payments reported to CMS, 2019-2025
26 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $488 · 2020: $373 · 2021: $458 · 2022: $583 · 2023: $365 · 2024: $301.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $667.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $666.53 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $473.51 | 2019-2023 | Rinvoq |
| Pfizer INC. | $387.63 | 2019-2024 | |
| Janssen Biotech, INC. | $358.58 | 2019-2022 | |
| Celgene Corporation | $265.57 | 2021-2024 | Zeposia |
| Acumed LLC | $202.70 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $133.22 | 2020-2024 | Entyvio |
| Janssen Scientific Affairs, LLC | $121.67 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $84.80 | 2019-2023 | Trulance |
| Romark Laboratories, Lc | $75.21 | 2020 | |
| Gilead Sciences, INC. | $55.29 | 2021-2023 | |
| Ucb, INC. | $50.27 | 2019 | |
| Genzyme Corporation | $50.17 | 2024 | |
| Redhill Biopharma INC. | $37.00 | 2020-2021 | |
| Evoke Pharma, INC. | $35.30 | 2020-2024 | |
| Daiichi Sankyo INC. | $32.51 | 2021-2022 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $32.00 | 2022 | |
| Amgen INC. | $30.18 | 2020-2021 | |
| Ironwood Pharmaceuticals, INC | $25.59 | 2019-2020 | |
| Phathom Pharmaceuticals, INC. | $17.65 | 2024 | Voquezna |
| Merck Sharp & Dohme LLC | $15.95 | 2021 | |
| Intercept Pharmaceuticals, INC. | $15.38 | 2019 | |
| Lilly USA, LLC | $15.17 | 2024 | Omvoh |
| Braintree Laboratories, INC. | $14.21 | 2019 | |
| Fresenius Kabi USA, LLC | $14.18 | 2023 | |
| Ferring Pharmaceuticals INC. | $12.79 | 2022 | |
| Nestle Healthcare Nutrition INC. | $12.52 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Shallcross listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.